OmniComm Systems has signed an agreement with Larix to support its clinical research needs for a five year, 31 site study. The partnership will enable Larix to provide its customers with quality products and services to manage complex ...
Cytochroma, a clinical stage specialty pharmaceutical company, has selected OmniComm Systems' eClinical Suite of applications for its two Phase III studies. OmniComm's eClinical Suite, including the EDC, CTMS, Safety, and Coding ...
Tags: Cytochroma, clinical stage, eClinical Suite, patient data, adverse events